PTEN is a tumor suppressor that tightly regulates the phosphoinositide-3-kinase/serine-threonine kinase/mammalian target of rapamycin (PI3K/AKT/mTOR) signaling axis, which is the main survival pathway involved in prostate cancer [5]. Here, MTOR is linked to neoplasm.